Compare LSAK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSAK | BBNX |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | South Africa | United States |
| Employees | N/A | 423 |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.8M | 493.1M |
| IPO Year | 2005 | N/A |
| Metric | LSAK | BBNX |
|---|---|---|
| Price | $4.76 | $17.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | 121.4K | ★ 977.2K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $659,701,000.00 | N/A |
| Revenue This Year | $14.35 | $34.90 |
| Revenue Next Year | $8.60 | $34.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.92 | N/A |
| 52 Week Low | $3.62 | $8.80 |
| 52 Week High | $5.54 | $32.71 |
| Indicator | LSAK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 65.78 |
| Support Level | $4.48 | $16.02 |
| Resistance Level | $5.05 | $32.52 |
| Average True Range (ATR) | 0.12 | 1.11 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 33.81 | 73.21 |
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.